Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in Angina With Non-Obstructive Coronary Artery Disease
NCT07741890Phase 2Not yet recruiting
- Sponsor
- The Christ Hospital
- Start
- Sep 2026
- Primary completion
- Dec 2028
01
Overview
A Phase 2 trial of dapagliflozin in angina pectoris, Coronary Microvascular Dysfunction (CMD), sponsored by The Christ Hospital. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
dapagliflozin
03
Conditions
angina pectorisCoronary Microvascular Dysfunction (CMD)
Beyond the preview
Go deeper on NCT07741890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07741890.